Disposable Syringes Market Size was valued at USD 14.7 Billion in 2023 and is expected to reach USD 29.06 billion by 2032, growing at a CAGR of 7.88% over the forecast period 2024-2032.
This report provides key statistical insights and emerging trends in the Disposable Syringes Market, focusing on the growing prevalence of injectable-dependent diseases and regional prescription patterns. It examines production and usage volumes, indicating increasing demand across both developed and emerging markets. It analyzes spending on injection equipment in the health care system, covering the government, insurers, and out-of-pocket. It also looks at how public health initiatives and vaccination campaigns affect how many syringes are being used. Additionally, it covers regulatory compliance trends and the rising adoption of safety-engineered syringes across regions.
The disposable syringes market is expected to grow at a strong pace owing to the rising demand for safety and hygiene in medical treatment. One significant driver for this market is the worldwide migration towards the adoption of single-use medical devices to fight against infections like HIV and hepatitis. Now, about 3.5 million people in the United States have hepatitis C according to data from the U.S. Centers for Disease Control and Prevention (CDC) highlighting the significance of disposable syringes in the medical field. The U.S. market for disposable syringes has increased significantly, rising from USD 3.63 billion in 2023 and reaching USD 7.07 by 2032 during this forecast period, registering a growth rate of about 7.70%. This growth is attributed to an increase in the prevalence of chronic diseases, improved vaccination programs, and rising adoption of safety-engineered syringes. Government expenditure on healthcare services, along with regulations mandating the use of protective syringes, contribute to the expansion of the market, reflecting its developed healthcare system combined with safety regulations. Increasing adoption of safety syringes that are a requirement by organizations such as the World Health Organization (WHO) has also been driving this market growth.
Drivers
Rising prevalence of chronic diseases such as diabetes and cancer, leading to increased use of disposable syringes for insulin delivery, chemotherapy, and other regular injectable therapies.
The increasing prevalence of chronic diseases, especially diabetes and cancer, which require frequent and safe injectable therapeutics, is one of the major factors projected to boost the growth of the global disposable syringes market. According to the International Diabetes Federation (IDF) 2024 report, states that 537 million adults, aged 20–79 years, are currently living with diabetes worldwide, with that number estimated to increase to 643 million by 2030. Many of these patients, particularly those living in areas lacking access to affordable pens or pumps, must administer their daily insulin doses with low-technology disposable syringes.
Similarly, the global burden of cancer is intensifying. Based on recently published estimates from the Global Cancer Observatory (GLOBOCAN) 2024, there were an estimated 20.6 million new cases of cancer worldwide, a substantial proportion of which need injectable therapy i.e., chemotherapy, targeted therapies administered via single-use disposable syringes to prevent contamination and ensure using sterile devices. Moreover, the rising utilization of home healthcare and point-of-care treatment models is driving the demand for syringes. Meanwhile, a 2024 report published by the Asia-Pacific Healthtech Alliance suggests as much as 45% of diabetic patients across the Asia-Pacific region are now self-managing their illness through home-administered insulin. These trends underscore that disposable syringes are uniquely becoming an integrated, cost-effective, and indispensable aspect of the clinical management of chronic diseases through multiple pathways including hospitals, clinics, and home care.
Restraint:
Environmental concerns over medical plastic waste, as disposable syringes contribute significantly to non-biodegradable medical waste, raising sustainability issues.
The major restraint to the growth of the disposable syringes market is medical plastic waste leading to environmental concerns. Disposable syringes are mostly made of polypropylene, a plastic that is not biodegradable and adds significantly to the global medical waste burden. According to the latest data from the World Health Organization (2024), healthcare facilities generate approximately 1.2 kilograms of hazardous waste per hospital bed per day, with a significant portion attributed to single-use devices like syringes. Moreover, according to the ISWA, more than 65% of all healthcare waste worldwide is plastic-based waste. The situation is further aggravated in the World especially in developing countries by improper disposal practices, which in turn contaminates the soil and water systems. Environmental regulations are tightening around the world the European Union has just announced single-use plastics restrictions in its new Green Deal, with an impact on syringe manufacturers required by 2030.
Moreover, waste management systems in low-resource settings are not adequately equipped to handle large volumes of used syringes, increasing the risk of illegal reuse and environmental degradation. These increasing both ecological and regulatory pressures are making manufacturers pay for sustainable alternatives, including biodegradable materials or recyclable syringe parts, which increase the costs of production & subsequently affect profit margins.
Opportunity:
Growth in demand for safety-engineered syringes, driven by increasing regulatory mandates to prevent needlestick injuries and cross-contamination.
One of the major opportunities in the disposable syringes market is the rise of demand for safety-engineered syringes due to international governmental institutions slightly tightening the regulations and raising awareness concerning healthcare worker safety. These syringes were invented to prevent needlestick injuries, which can cause bloodborne infections like HIV and hepatitis B and C. According to the World Health Organization (2024), approximately 2 million healthcare workers have needlestick injuries per year, with most caused by the reuse or unsafe disposal of traditional syringes. As a result, agencies such as the U.S. Occupational Safety and Health Administration (OSHA) and the European Medicines Agency (EMA) are strengthening requirements for implementing safety syringes in medical institutions. In 2024, the U.S. Department of Health and Human Services issued updated compliance guidelines to public health programs, recommending the use of auto-disable and retractable syringes.
In addition, in April 2024, India’s Ministry of Health issued a national regulation promoting the use of reuse-prevention syringes in all government hospitals. This change should dramatically accelerate domestic manufacturing and adoption. This trend is also driven by technological innovations. For example, Becton, Dickinson, and Company (BD) released 2024 new products with SmartSlip safety syringes with passive safety design mechanisms that can retract the needle after use automatically, thus ensuring user safety and eliminating the need for any training.
Challenge:
Supply chain disruptions and raw material shortages, especially in low- and middle-income countries, leading to inconsistent availability and delayed healthcare interventions.
Supply chain disruption and raw material shortages have emerged as one the major challenges for the disposable syringes market today, especially in low- and middle-income countries (LMICs). Disposable syringes are made primarily of medical-grade plastics such as polypropylene and polyethylene. However, recent global fluctuations in polymer resin prices up by nearly 18% in 2024, according to the Plastics Industry Association have created volatility in raw material availability and procurement costs. In addition, global trade in vital elements like needle-grade stainless steel and rubber seals has also been disrupted by increasing geopolitical tensions and tightening rules on cross-border investments. In early 2025, the International Medical Device Manufacturers Association published a survey that accounted for close to 42% of syringe manufacturers who reported delays in obtaining crucial raw materials which had an effect on their production timelines.
Transportation bottlenecks and higher freight costs have compounded the challenge, especially in places such as Southeast Asia and Sub-Saharan Africa which saw logistics costs climb 23% year-over-year. These factors result in unequal availability and restricted access to vital injection supplies in medical care centers. Consequently, procurement groups and healthcare facilities are left struggling amidst uncertainty, often resulting in postponed treatment timelines and heightened reliance on more expensive substitutes or urgent shipments, which add further pressure on already constrained healthcare budgets.
By Syringe Type
In 2023, conventional syringes dominated the disposable syringes market with a revenue share of 54%. These costs make them ideal for both clinical and homecare implementation, which is a major factor driving this dominance. Conventional syringes are mainly used for general injections and blood extractions, making them one of the most commonly adopted medical devices in hospitals and other healthcare facilities around the world. The reliability and safety of these syringes are largely guided by the regulatory framework established by the U.S. Food and Drug Administration (FDA), which has been tasked with the responsibility of ensuring their quality through a number of measures. Furthermore, conventional syringes are the most commonly used in low-resource settings due to the possible prohibitive cost of advanced safety syringes. In the case of developing countries, immunization for organ transplanting has a high amount of affordability with conventional disposable syringes.
However, despite their widespread use, conventional syringes present problems like the potential for needle-stick injuries and the spread of infection through improper handling. To address this issue, WHO and others promote incremental shifts to safer systems, including auto-disable or retractable syringes. Nevertheless, the cost benefits of traditional syringes render them vital for many countries. Technological improvements have also made traditional syringes easier to use. For instance, manufacturers are working towards enhancing the needle sharpness as well as barrel transparency for greater accuracy during medical processes. These innovations have further solidified their position as a preferred choice among healthcare providers.
By End-Use
In 2023, hospitals emerged as the largest end-use segment for disposable syringes, with the segment accounting for approximately 51% of revenue share. This is mainly due to the volume of inpatient and outpatient procedures that require injections or fluid extractions. According to data from the American Hospital Association (AHA), over 36 million patients were admitted to U.S. hospitals annually as of 2019, with over 108 million outpatient visits recorded. This higher patient volume also requires a steady supply of disposable syringes to meet infection-control standards.
Government initiatives have further supported this trend. For example, Medicare’s Hospital Value-Based Purchasing Program rewards hospitals that use high-quality medical supplies that improve patient outcomes and reduce hazards like cross-contamination. The increase in the prevalence of chronic diseases such as diabetes has also played a major role in the growth of this segment. Therefore, Hospitals use disposable syringes for insulin injections for diabetic patients. Moreover, held that innovation in clinical asset management structure, disposable therapeutic products can be tracked with high efficiency, ensuring there will be no humanitarian interruption during lifesaving operations.
The North American region dominated the disposable syringes market in 2023 with 38% of the global market share. This leadership is attributed to factors like sophisticated healthcare infrastructure, higher sensitivity towards infection management among the population, and state action in favor of one-time-use medical devices. There has been particularly strong demand in the U.S., where chronic diseases are more prevalent including diabetes and cancer and frequent injectable treatments are necessary. According to the Centers for Disease Control and Prevention (CDC), 37.3 million Americans had diabetes as of 2022, further driving syringe usage. Vaccination efforts, such as those for influenza and pediatric immunizations, have also strengthened demand.
In contrast, the Asia-Pacific region was the fastest developing region with a considerable CAGR in the forecast period. Growth is driven by rapid urbanization, expanding healthcare infrastructure, and government-backed immunization in countries such as India and China. For example, India’s Universal Immunization Program delivers millions of vaccines each year, making it essential for this program to have a steady supply of disposable syringes. Likewise, China’s emphasis on reducing hospital-acquired infections is driving greater use of single-use medical devices.
Becton, Dickinson and Company (BD Plastipak, BD SafetyGlide)
B. Braun Melsungen AG (Omnifix, Injekt)
Terumo Corporation (Neolus, SurGuard)
Nipro Corporation (Nipro Syringe, Nipro SafeTouch)
Hindustan Syringes & Medical Devices Ltd. (Dispo Van, Kojak Selinge)
Smiths Medical (Jelco Hypodermic Syringes, Medfusion)
Cardinal Health (Monoject, Magellan)
Gerresheimer AG (Gx RTF Syringes, Gx InnoSafe)
SCHOTT AG (SCHOTT TopPac, SCHOTT syriQ)
Weigao Group (Weigao Disposable Syringes, Safety Syringes)
Users of Disposable Syringes
Mayo Clinic
Cleveland Clinic
Johns Hopkins Hospital
Apollo Hospitals
Mount Sinai Health System
Fortis Healthcare
Kaiser Permanente
All India Institute of Medical Sciences (AIIMS)
National Health Service (NHS), UK
Singapore General Hospital
In February 2025, BD announced an increase in its prefilled syringe production capacity at its Nebraska facility, driven by the growing global need for vaccination programs.
Nipro established its manufacturing unit in India to meet the growing demand for Asia-Pacific markets in January 2025.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 14.7 Billion |
| Market Size by 2032 | USD 29.06 Billion |
| CAGR | CAGR of 7.8% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Syringe Type (Safety Syringes {Retractable Safety Syringes, Non-retractable Safety Syringes}, Conventional Syringes) • By End-use (Hospital, Outpatient Facilities, Research & Manufacturing) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Becton, Dickinson and Company, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Hindustan Syringes & Medical Devices Ltd., Smiths Medical, Cardinal Health, Gerresheimer AG, SCHOTT AG, Weigao Group. |
Ans. The projected market size for the Disposable Syringes Market is USD 29.06 billion by 2032.
Ans: The safety syringes segment is growing with the fastest CAGR during the forecast period.
Ans. The CAGR of the Disposable Syringes Market is 7.88% during the forecast period of 2024-2032.
Ans: Rising prevalence of chronic diseases such as diabetes and cancer, leading to increased use of disposable syringes for insulin delivery, chemotherapy, and other regular injectable therapies.
Ans: The Hospital segment dominated the Disposable Syringes Market.
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.2 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Production and Usage Volume of Disposable Syringes (2020–2023, Forecast to 2032)
5.2 Healthcare Spending on Injection Equipment (2023)
5.3 Public Health Initiatives and Vaccination Drives (2023)
5.4 Regulatory Compliance and Safety Standards Penetration (2023)
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and supply chain strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Disposable Syringes Market Segmentation, By Syringe Type
7.1 Chapter Overview
7.2 Safety Syringes
7.2.1 Safety Syringes Market Trends Analysis (2020-2032)
7.2.2 Safety Syringes Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.3 Retractable Safety Syringes
7.2.3.1 Retractable Safety Syringes Market Trends Analysis (2020-2032)
7.2.3.2 Retractable Safety Syringes Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.4 Non-retractable Safety Syringes
7.2.4.1 Non-retractable Safety Syringes Market Trends Analysis (2020-2032)
7.2.4.2 Non-retractable Safety Syringes Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Conventional Syringes
7.3.1 Conventional Syringes Market Trends Analysis (2020-2032)
7.3.2 Conventional Syringes Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Disposable Syringes Market Segmentation, By End-use
8.1 Chapter Overview
8.2 Hospitals
8.2.1 Hospitals Market Trends Analysis (2020-2032)
8.2.2 Hospitals Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Outpatient Facilities
8.3.1 Outpatient Facilities Market Trends Analysis (2020-2032)
8.3.2 Outpatient Facilities Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Research & Manufacturing
8.4.1 Research & Manufacturing Market Trends Analysis (2020-2032)
8.4.2 Research & Manufacturing Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Regional Analysis
9.1 Chapter Overview
9.2 North America
9.2.1 Trends Analysis
9.2.2 North America Disposable Syringes Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.2.3 North America Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.2.4 North America Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.2.5 USA
9.2.5.1 USA Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.2.5.2 USA Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.2.6 Canada
9.2.6.1 Canada Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.2.6.2 Canada Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.2.7 Mexico
9.2.7.1 Mexico Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.2.7.2 Mexico Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3 Europe
9.3.1 Eastern Europe
9.3.1.1 Trends Analysis
9.3.1.2 Eastern Europe Disposable Syringes Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.1.3 Eastern Europe Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.3.1.4 Eastern Europe Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.1.5 Poland
9.3.1.5.1 Poland Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.3.1.5.2 Poland Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.1.6 Romania
9.3.1.6.1 Romania Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.3.1.6.2 Romania Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.1.7 Hungary
9.3.1.7.1 Hungary Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.3.1.7.2 Hungary Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.1.8 Turkey
9.3.1.8.1 Turkey Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.3.1.8.2 Turkey Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.1.9 Rest of Eastern Europe
9.3.1.9.1 Rest of Eastern Europe Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.3.1.9.2 Rest of Eastern Europe Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.2 Western Europe
9.3.2.1 Trends Analysis
9.3.2.2 Western Europe Disposable Syringes Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.2.3 Western Europe Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.3.2.4 Western Europe Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.2.5 Germany
9.3.2.5.1 Germany Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.3.2.5.2 Germany Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.2.6 France
9.3.2.6.1 France Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.3.2.6.2 France Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.2.7 UK
9.3.2.7.1 UK Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.3.2.7.2 UK Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.2.8 Italy
9.3.2.8.1 Italy Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.3.2.8.2 Italy Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.2.9 Spain
9.3.2.9.1 Spain Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.3.2.9.2 Spain Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.2.10 Netherlands
9.3.2.10.1 Netherlands Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.3.2.10.2 Netherlands Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.2.11 Switzerland
9.3.2.11.1 Switzerland Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.3.2.11.2 Switzerland Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.2.12 Austria
9.3.2.12.1 Austria Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.3.2.12.2 Austria Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.2.13 Rest of Western Europe
9.3.2.13.1 Rest of Western Europe Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.3.2.13.2 Rest of Western Europe Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.4 Asia Pacific
9.4.1 Trends Analysis
9.4.2 Asia Pacific Disposable Syringes Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.4.3 Asia Pacific Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.4.4 Asia Pacific Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.4.5 China
9.4.5.1 China Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.4.5.2 China Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.4.6 India
9.4.5.1 India Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.4.5.2 India Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.4.5 Japan
9.4.5.1 Japan Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.4.5.2 Japan Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.4.6 South Korea
9.4.6.1 South Korea Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.4.6.2 South Korea Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.4.7 Vietnam
9.4.7.1 Vietnam Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.2.7.2 Vietnam Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.4.8 Singapore
9.4.8.1 Singapore Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.4.8.2 Singapore Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.4.9 Australia
9.4.9.1 Australia Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.4.9.2 Australia Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.4.10 Rest of Asia Pacific
9.4.10.1 Rest of Asia Pacific Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.4.10.2 Rest of Asia Pacific Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.5 Middle East and Africa
9.5.1 Middle East
9.5.1.1 Trends Analysis
9.5.1.2 Middle East Disposable Syringes Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.1.3 Middle East Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.5.1.4 Middle East Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.5.1.5 UAE
9.5.1.5.1 UAE Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.5.1.5.2 UAE Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.5.1.6 Egypt
9.5.1.6.1 Egypt Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.5.1.6.2 Egypt Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.5.1.7 Saudi Arabia
9.5.1.7.1 Saudi Arabia Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.5.1.7.2 Saudi Arabia Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.5.1.8 Qatar
9.5.1.8.1 Qatar Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.5.1.8.2 Qatar Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.5.1.9 Rest of Middle East
9.5.1.9.1 Rest of Middle East Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.5.1.9.2 Rest of Middle East Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.5.2 Africa
9.5.2.1 Trends Analysis
9.5.2.2 Africa Disposable Syringes Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.2.3 Africa Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.5.2.4 Africa Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.5.2.5 South Africa
9.5.2.5.1 South Africa Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.5.2.5.2 South Africa Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.5.2.6 Nigeria
9.5.2.6.1 Nigeria Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.5.2.6.2 Nigeria Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.5.2.7 Rest of Africa
9.5.2.7.1 Rest of Africa Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.5.2.7.2 Rest of Africa Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.6 Latin America
9.6.1 Trends Analysis
9.6.2 Latin America Disposable Syringes Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.6.3 Latin America Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.6.4 Latin America Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.6.5 Brazil
9.6.5.1 Brazil Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.6.5.2 Brazil Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.6.6 Argentina
9.6.6.1 Argentina Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.6.6.2 Argentina Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.6.7 Colombia
9.6.7.1 Colombia Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.6.7.2 Colombia Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.6.8 Rest of Latin America
9.6.8.1 Rest of Latin America Disposable Syringes Market Estimates and Forecasts, By Syringe Type (2020-2032) (USD Billion)
9.6.8.2 Rest of Latin America Disposable Syringes Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10. Company Profiles
10.1 Becton, Dickinson and Company
10.1.1 Company Overview
10.1.2 Financial
10.1.3 Products/ Services Offered
110.1.4 SWOT Analysis
10.2 B. Braun Melsungen AG
10.2.1 Company Overview
10.2.2 Financial
10.2.3 Products/ Services Offered
10.2.4 SWOT Analysis
10.3 Terumo Corporation
10.3.1 Company Overview
10.3.2 Financial
10.3.3 Products/ Services Offered
10.3.4 SWOT Analysis
10.4 Nipro Corporation
10.4.1 Company Overview
10.4.2 Financial
10.4.3 Products/ Services Offered
10.4.4 SWOT Analysis
10.5 Hindustan Syringes & Medical Devices Ltd.
10.5.1 Company Overview
10.5.2 Financial
10.5.3 Products/ Services Offered
10.5.4 SWOT Analysis
10.6 Smiths Medical
10.6.1 Company Overview
10.6.2 Financial
10.6.3 Products/ Services Offered
10.6.4 SWOT Analysis
10.7 Cardinal Health
10.7.1 Company Overview
10.7.2 Financial
10.7.3 Products/ Services Offered
10.7.4 SWOT Analysis
10.8 Gerresheimer AG
10.8.1 Company Overview
10.8.2 Financial
10.8.3 Products/ Services Offered
10.8.4 SWOT Analysis
10.9 SCHOTT AG
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
10.10 Weigao Group.
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
11. Use Cases and Best Practices
12. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Syringe Type
Safety Syringes
Retractable Safety Syringes
Non-retractable Safety Syringes
Conventional Syringes
By End-use
Hospital
Outpatient Facilities
Research & Manufacturing
Request for Segment Customization as per your Business Requirement: Segment Customization Request
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
The Alzheimer’s Therapeutics Market Size was valued at USD 3.78 Billion in 2023 and will reach USD 13.42 Billion by 2032, with a growing CAGR of 15.14% during 2024-2032.
Iron Deficiency Anemia Therapy Market size was estimated at USD 4.69 billion in 2023, projected to reach USD 8.82 billion by 2032, growing at a CAGR of 7.26%.
Coagulants Market was valued at USD 9.94 billion in 2023 and is expected to reach USD 17.63 billion by 2032, growing at a CAGR of 6.62% from 2024 to 2032.
The Cardiac Rhythm Management Devices Market was valued at USD 18.51 billion in 2023, projected to reach USD 32.35 billion by 2032, growing at a CAGR of 6.40%.
The Endoprosthesis Market Size was valued at USD 25.94 billion in 2023 and is expected to reach USD 60.39 billion by 2032 and grow at a CAGR of 9.86% over the forecast period 2024-2032.
Surgical Imaging Market was valued at USD 148 billion in 2023 and is expected to reach USD 340.5 billion by 2032 and grow at a CAGR of 9.7% from 2024 to 2032.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
